Clinical Trials Logo
  1. Home
  2. Healthy Subjects
  3. NCT03107403
  4. Details
NCT03107403 Clinical Trial

Dreams and Bereavement

Healthy Subjects Clinical Trial

— DreamDeath  

Official title:
Investigation of the Links Between Waking-life and Dream Content in the Case of the Death of a Close Relative

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03107403
Other study ID # 69HCL17_0075
Secondary ID 2017-A00640-53
Status Completed
Phase N/A
First received
Last updated
Start date October 9, 2018
Est. completion date April 9, 2023

Study information
Verified date February 2024
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate a possible role of dreaming in emotion regulation testing whether dreaming of a close relative recently deceased is correlated with a positive evolution of the bereavement process

Recruitment information / eligibility
Status Completed
Enrollment 50
Est. completion date April 9, 2023
Est. primary completion date April 9, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age > or = 18 years old - the death of a close relative in the last 3 months Exclusion Criteria: - history of psychiatric and neurologic disease

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• web form
The scale assessing the bereavement process is the one reported in Teissier 2010

Locations
Country Name City State
France Hospices Civils de Lyon Hôpital le Vinatier/Inserm Bron

Sponsors (1)
Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 1
Primary Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 90
Primary Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 180
Primary Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 270
Primary Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 360
Secondary Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 1
Secondary Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 90
Secondary Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 180
Secondary Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 270
Secondary Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process Day 360
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1